T cells of lupus and molecular targets for immunotherapy

Journal of Clinical Immunology

Volumn 17, Issue 1, 1997, Pages 11-20

  Datta, Syamal K ^a   Kaliyaperumal, Arunan ^a   Desai Mehta, Ami ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

anti DNA autoantibody; autoimmune disease; CD40 ligand; immunotherapy; nucleosomal epitopes; systemic lupus erythematosus; T cell receptors

Indexed keywords

CYTOKINE; DNA ANTIBODY; GLYCOPROTEIN GP 39; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; ETIOLOGY; HUMAN; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES;

EID: 0031059619     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027328226918     Document Type: Review

References (150)

1. Mohan C, Dalla SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209-220, 1995
2. Boumpas DT, Austin HA, Fessier BJ, Balow JE, Klippel JH, Lockshin MD: Systemic lupus erythematosus: Emerging concepts. 1. Renal, neuropschyatric, cardiovascular, pulmonary and hematologic disease. Ann Intern Med 122:940-950, 1995
3. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M: A model for disease heterogeneity in systemic lupus erythematosus: relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arth Rheum 32:826-836, 1989
4. Salmon JE, Millard S, Schachter LA. et al.: FcYRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97:1348-1354, 1996
5. Tan EM: Anti-nuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
6. Hardin JA, Thomas JO: Antibodies to histones in systemic lupus erythematosus: Localization of prominent autoantigens on histone HI and H2B. Proc Natl Acad Sci USA 80:7410-7414, 1983
7. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179: 1317-1330, 1994
8. Stewart A, Huang C, Long A, Stollar B, Schwartz R: VH-gene representation in autoantibodies reflects the normal B cell repertoire. Immunol Rev 128:101-122, 1992
9. Madaio MP, Hodder S, Schwartz RS, Stollar BD: Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 132:872-876, 1984
10. Gilkeson GS, Pippen AMM, Pisetsky DS: Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 95: 1398-1402, 1995
11. Datta SK, Mohan C, Desai-Mehta A: Mechanisms of the pathogenic autoimmune response in lupus: Prospects for specific immunotherapy. Immunol Res 14:132-147, 1995
12. Howie JB, Helyer BJ: The immunology and pathology of NZB mice. Adv Immunol 9:215-268, 1968
13. Datta SK, Schwartz RS: Genetics of expression of xenotropic virus and autoimmunity in NZB mice. Nature 263:412-415, 1976
14. Datta SK, Schwartz RS: Mendelian segregation of loci controling xenotropic virus production in NZB crosses. Virology 83:449-452, 1977
15. Datta SK, Manny N, Andrzejewski C, Andre-Schwartz J, Schwartz RS: Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand Black mice. I. Xenotropic virus. J Exp Med 147:854-871, 1978
16. Datta SK, McConahey PJ, Manny N, Theofilopoulos AN, Dixon FJ, Schwartz RS: Genetic studies of autoimmunity and retrovirus expression in crosses of NZB mice. II. The viral envelope glycoprotein gp 70. J Exp Med 147:872-881, 1978
17. Eastcott JW, Schwartz RS, Datta SK: Genetic analysis of the inheritence of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB X SWR crosses. J Immunol 131:2232-2239, 1983
18. Datta SK: A search for the underlying mechanisms of systemic autoimmune disease in the NZB × SWR model. Clin Immunol Immunopathol 51:141-156, 1989
19. Sercarz EE, Datta SK: Mechanisms of autoimmunization: Perspective from the mid-90s. Curr Opin Immunol 6:875-881, 1994
20. Drake CG, Babcock SK, Palmer E, Kotzin BL: Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc Natl Acad Sci USA 91:4062-4066, 1994
21. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219-229, 1994
22. Kono DH, Burlingame RW, Owens DG, et al.: Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 91:10168-10172, 1994
23. Kelly VE, Winkelstein A: Age and sex-related glomerulonephritis in New Zealand white mice. Clin Immunol Immunopathol 16:142-150, 1980
24. Yoshiki T, Mellors RC, Strand M, August JT: The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand Mice. J Exp Med 140:1011-1027, 1974
25. Schwartz RS: Viruses and systemic lupus erythematosus. N Engl J Med 293:132-138, 1975
26. Lewis RM, Tannenberg W, Smith C, Schwartz RS: C-type viruses and systemic lupus erythematosus. Nature 252:78-79, 1974
27. Talal N: Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arth Rheum 13:887-894, 1970
28. Lambert PH, Dixon FJ: Genesis of anti-nuclear antibody in NZB/W mice: Role of genetic factors and of viral infections. Clin Exp Immunol 6:829-839, 1970
29. Levy JA: Xenotropic C-type viruses and autoimmune disease. J Rheumatol 2:135-148, 1975
30. Panem S, Ordonez NG, Kerstein WH, Katz AI, Spargo BH: C-type virus expression insystemic lupus erythematosus. N Engl J Med 295:470-475, 1976
31. Mellors RC, Mellors JW: Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proc Natl Acad Sci USA 73:233-237, 1976
32. Markenson JA, Phillips PE: Type-C viruses in systemic lupus erythematosus. Arth Rheum 21:266-270, 1978
33. Strand M, August JT: Type-C RNA virus gene expression in human tissue. J Virol 14:1584-1596, 1974
34. Krieg AM, Steinberg AD: Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J Clin Invest 86:809-816, 1990
35. Datta SK, Owen FL, Womack JE, Riblet RJ: Analysis of recombinant inbred lines derived from autoimmune (NZB) and high leukemia (C58) strains: Independent multigenic systems control B cell hyperactivity. retrovirus expression and autoimmunity. J Immunol 129:1539-1544, 1982
36. Pisetsky DS, McCarty GA, Peters DV: Mechanisms of autoantibody production in autoimmune MRL mice. J Exp Med 152: 1302-1310, 1980
37. Cohen PL, Eisenberg RA: Anti-idiotypic antibodies to the coomb's antibody in NZB F1 mice. J Exp Med 156:173-180, 1982
38. bm12 mice. J Immunol 145:94-101, 1990
39. Gavalchin J, Nicklas J, Eastcott JW, et al.: Lupus prone (SWR × NZB)F1 mice produce potentially nephritogenic autoantibodies inherited from the normal SWR parent. J Immunol 134:885-894, 1985
40. Gavalchin J, Seder RA, Datta SK: The NZB × SWR model of lupus nephritis. I. Cross-reactive idiotypes of monoclonal anti-DNA antibodies in relation to antigenic specificity, charge and allotype. Identification of interconnected idiotype families inherited from the normal SWR and the autoimmune NZB parents. J Immunol 138:128-137, 1987
41. Gavalchin J, Datta SK: The NZB × SWR model of lupus nephritis. II. Autoanlibodies deposited in renal lesions show a restricted idiotypic diversity. J Immunol 138:138-148, 1987
42. Datta SK, Gavalchin J: The origins of pathogenic anti-DNA idiotypes in the (NZB × SWR)F1 model of lupus nephritis. Ann NY Acad Sci 475:47-58, 1986
43. Datta SK, Patel H, Berry D: Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med 165:1252-1268, 1987
44. Shivakumar S, Tsokos GC, Datta SK: T cell receptor α/β expressing double negative (CD4-/CDS-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143: 103-112, 1989
45. Vlahakos DV, Foster MH, Adams S, et al.: Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 41:1690-1700, 1992
46. O'Keefe TL, Bandyopadhyay S, Datta SK, Imanishi-Kari T: Variable region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol 144:4275-4283, 1990
47. Tillman DM, Jou N-T, Hill RJ, Marion TN: Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB × NZW)F1 mice. J Exp Med 176:761-779, 1992
48. Shlomchik MJ, Mascelli M, Shan H, et al.: Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171:265-292, 1990
49. Tsao BP, Ebling FM, Roman C, Panosian-Sahakian N, Calame K, Hahn BH: Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest 85:530-540, 1990
50. Kieber-Emmons T, Foster MH, Williams WV, Madaio MP: Structural properties of a subset of nephritogenic anti-DNA antibodies. Immunol Res 13:172-185, 1994
51. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 10:731-757, 1992
52. Radic MZ, Weigert M: Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12:487-520, 1494
53. Ebling F, Hahn BH: Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: Comparison of antibodies in serum and renal eluates. Arth Rheum 23:392-403, 1980
54. Gauthier VJ, Mannik M: A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition in glomeruli. J Immunol 145:3348-3352, 1990
55. Schmiedke TMJ, Stockl FW, Weber R, Sugisaki Y, Batsford SR, Vogt A: Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med 169:1879-1894, 1989
56. Kramers C, Hylkema MN, van Bruggen MCJ, et al.: Antinucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94:568-577, 1994
57. Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: A major immunogen for the pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177:1367-1381, 1993
58. Ohnishi K, Ebling FM, Mitchell B, Singh RR, Hahn BH, Tsao BP: Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol 6:817-827, 1994
59. Suenaga R, Abdou NI: Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol 94:418-422, 1993
60. Suzuki N, Harada T, Mizushima Y, Sakane T: Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 151:1128-1136, 1993
61. Winkler TH, Fehr H, Kalden JR: Analysis of imnunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 22:1719-1728, 1992
62. Ghatak S, Sainis K, Owen FL, Datta SK: T cell receptor β and I-Aβ chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB × SWR crosses. Proc Natl Acad Sci USA 84:6850-6853, 1987
63. O'Keefe TL, Datta SK, Imanishi-Kari T: Cationic residues in pathogenic anti-DNA autoantibodies arise by mutations of a germline gene that belongs to a large VH gene subfamily. Eur J Immunol 22:619-624, 1992
64. Rajagopalan S, Zordan T, Tsokos GC, Datta SK: Pathogenic anti-DNA autoantibody inducing T helper cell lines from patients with active lupus nephritis: Isolation of CD4-/CD8- T helper cell lines that express the gamma/δ T-cell receptor. Proc Natl Acad Sci USA 87:7020-7024, 1990
65. Sainis K, Datta SK: CD4+ T cell lines with selective patterns of autoreactivity as well as CD4-/CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB × SWR model of lupus nephritis. J Immunol 140:2215-2224, 1988
66. Adams S, Zordan T, Sainis K, Datta SK: T cell receptor Vβ genes expressed by IgG anti-DNA autoantibody inducing T cells in lupus nephritis: Forbidden receptors and double negative T cells. Eur J Immunol 20:1435-1443, 1990
67. Adams S, Leblanc P, Datta SK: Junctional region sequences of T-cell receptor β chain genes expressed by pathogenic anti-DNA autoantibody-inducing T helper cells from lupus mice: Possible selection by cationic autoantigens. Proc Natl Acad Sci USA 88:11271-11275, 1991
68. Mao C, Osman GE, Adams S, Datta SK: T cell receptor alpha-chain repertoire of pathogenic autoantibody-inducing T cells in lupus mice. J Immunol 152:1462-1470, 1994
69. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK: Structure and specificity of T-cell receptors expressed by pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 95:531-541, 1995
70. Jorgensen JL, Esser U, Reay PA, Fazekas de St. Groth B, Davis MM: Mapping T cell receptor/peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224-230, 1992
71. Atkinson MJ, Bell DA, Singhal SK: A naturally occuring polyclonal B cell activator of normal and autoantibody responses. J Immunol 135:2524-2533, 1985
72. Datta SK, Rajagopalan S, O'Keefe TL, Ghatak S, Imanishi-Kari T: Pathogenic anti-DNA autoantibodies and pathogenic autoantibody-inducing T cells. In Molecular Immunobiology of Self-Reactivity, CA Bona. A Kaushik (eds). New York: Marcel Decker, 1992, pp 133-153
73. Rumore P, Steinman C: Endogenous circulating DNA in systemic lupus erythematosus. Occurrences as multimeric complexes bound to histones. J Clin Invest 86:69-74, 1990
74. Fournie GJ, Lule J, Dueymes J-M, et al.: Plasma DNA in patients undergoing hemodialysis at hemofiltration: Cytolysis in artificial kidney is responsible for the release of DNA in circulation. Am J Nephrol 9:384-391, 1989
75. Atanassov C, Briand JP, Bonnier D, Van Regenmortel MHV, Muller S: New Zealand white rabbits immunized with RNA-complexed total histones develop an autoimmune-like response. Clin Exp Immunol 86:124-133, 1991
76. Linker-Israeli M, Quisimoro FP, Horwitz DA: CDX+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arth Rheum 33:1216-1225, 1990
77. Singh RR, Kumar V, Ebling FM, et al.: T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine SLE. J Exp Med 181:2017-2027, 1995
78. Rothfield NF, Stollar BD: The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest 46:1785-1794, 1967
79. Burlingame RW, Rubin RL, Balderas RS, Theotilopoulos AN: Genesis and evolution of anti-chromatin autoantibodies in murine lupus implicates immunization with self antigen. J Clin Invest 91:1687-1696, 1993
80. Burlingame RW, Boey ML, Starkebaum G, Rubin RL: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94:184-192, 1994
81. Chabre H, Amoura Z, Piette J-C, Godeau P, Bach J-F, Koutouzov S: Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arth Rheum 38:1485-1491, 1995
82. Bernstein KA, DiValerio R, Lefkowith JB: Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 154:2424-2433, 1995
83. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR: The specificity and regulation of T cell responsiveness to allergens. Annu Rev Immunol 9:67-95, 1991
84. Kaliyaperumal A, Mohan C, Wu W, Datta SK: Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J Exp Med 183:2459-2469, 1996
85. Desai DD, Krishnan MR, Swindle JT, Marion TN: Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 151:1614-1626, 1993
86. Kanai Y, Takeda O, Kanai Y, Miura K, Kurosawa Y: Novel autoimmune phenomena induced in vivo by a new DNA binding protein Nuc: a study on MRL/n mice, Immunol Lett 39:83-89, 1994
87. Fredriksen K, Osei A, Sundsfjord A, Traavik T, Rekvig OP: On the biological origin of anti-dsDNA antibodies: systemic lupus erythematosus related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZB × NZW)F1 hybrids, but not in normal mice. Eur J Immunol 24:66-70, 1994
88. James JA, Gross T, Scofield RH, Harley JB: Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP ans PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181:453-461, 1995
89. Llorente L, Zou W, Levy Y, et al.: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of systemic lupus erythematosus. J Exp Med 181:839-844, 1995
90. Sornasse T, Larenas PV, Davis KA, DeVries JE, Yssel H: Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells analyzed at the single cell level. J Exp Med 184:473-483, 1996
91. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879, 1994
92. Rothstein TL, Wang JKM, Panka DJ, et al.: Protection against Fas-dependent Th-1 mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163-165, 1995
93. Singh RR, Hahn BH, Sercarz EE: Neonatal peptide exposure can prime T cells and upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated immunity. J Exp Med 183:1613-1622, 1996
94. Lake P, Mitchison NA: Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harbor Symp Quant Biol 41:589-595, 1976
95. Lehman P, Forsthuber T, Miller A, Sercarz E: Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157, 1992
96. Ando DG, Sercarz EE, Hahn BH: Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol 138:3185-3190, 1987
97. Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA: T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol 152:6011-6016, 1994
98. Naiki M, Chiang B-L, Cawley D, et al.: Generation and characterization of cloned helper T cell lines for anti-DNA responses in NZB.H-2bm12 mice. J Immunol 149:4109-4115, 1992
99. Portanova JP, Arndt RE, Kotzin BL: Selective production of autoantibodies in graft-versus-host induced and spontaneous murine lupus. Predominant reactivity with histone regions accessible in chromatin. J Immunol 140:755-760, 1988
100. Mamula MJ, Fatenejad S, Craft J: B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 152:1453-1461, 1994
101. Noelle RJ, Ledbetter JA, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today 13:431-433, 1992
102. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM, Chess L: Molecular interaction mediating T-B lymphocyte collaboration in human lymphoid follicles. Role T cell-B cell activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149:3817-3826, 1992
103. Clark EA, Ledbetter JA: How B and T cells talk to each other. Nature 367:425-428, 1994
104. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ: The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151:2497-2510, 1993
105. Banchereau J, Bazan F, Blanchard D, et al.: The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922, 1994
106. Spriggs MK, Armitage RJ, Stockbine L, et al.: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543-1550, 1992
107. Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480, 1995
108. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97: 2063-2073, 1996
109. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330, 1993
110. Hill A, Chapel H: X-linked immunodeficiency. The fruits of cooperation. Nature 361:494, 1993
111. Noelle RJ, Roy M, Shepherd DM, Stamencovic I, Ledbetter JA, Aruffo A: A novel ligand on activated helper T cells binds CD40 and transduces the signal for the cognate activation of B cells. Proc Natl Acad Sci USA 89:6550-6554, 1992
112. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925-935, 1993
113. Kennedy MK, Mohler KM, Shanebeck KD, et al.: Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur J Immunol 24:116-123, 1994
114. Buhlmann JE, Foy TM, Aruffo A, et al.: In the absence of a CD40 signal B cells are tolerogenic. Immunity 2:645-653, 1995
115. Lederman S, Yellin MJ, Cleary AM, et al.: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol 152:2163-2171, 1994
116. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen driven selection in germinal centers. Nature 342:929-931, 1989
117. Tsubata T, Wu J, Honjo T: B cell apoptosis induced by antigen receptor crosslinking is blocked by a T cell signal through CD40. Nature 364:645-648, 1993
118. Parry SL, Hasbold J, Holman M, Klaus GGB: Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 152:2821-2829, 1994
119. Schattner EJ, Elkon KB, Yoo D-H, et al.: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557-1565, 1995
120. Wang Z, Karras JG, Howard RG, Rothstein TL: Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J Immunol 155:3722-3725, 1995
121. Gleichmann E, van Elven EH, van der Veen JPW: A systemiclupus erythematosus (SLE) like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12:152-159, 1982
122. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE: The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 154:4996-5010, 1995
123. Facchetti F, Apppiani C, Salvi L, Levy J, Notarangelo LD: Immunohistologic analysis of ineffective CD40-CD40 Ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 154:6624-6633, 1995
124. Ware CF, Crowe PD, Vanarsdale TL, et al.: Tumor necrosis factor (TNF) receptor family expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 147:4229-4238, 1991
125. Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826-837, 1996
126. Stuber E, Strober W, Neurath M: Blocking the CD40L-CD40 interactions in vivo specifically prevents the priming of T helper 1 cells through the inhibition of Interieukin 12 secretion. J Exp Med 183:693-698, 1996
127. Klaus SJ, Pinchuk LM, Ochs HD, et al.: Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 152:5643-5652, 1994
128. de Boer M, Kasran A, Kwekkeboom J, Walter H, Vandenberghe P, Ceuppens JL: Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, IL-4 secretion and efficient help for antibody production by B cells. Eur J Immunol 23:3120-3125, 1993
129. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7:445-480, 1989
130. Kammer GM, Khan I, Malemud C: Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 94:422-430, 1994
131. Vassilopoulos D, Kovacs B, Tsokos GC: TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 155:2269-2281, 1995
132. Albertini RJ, O'Neil JP, Nicklas JA, Heintz NH, Kelleher PC: Alterations of the hprt gene in normal human in vivo-derived 6-thioguanine resistant T lymphocytes. Nature 316:369-371, 1985
133. Allegretta M, Nicklas JA, Sriram S, Albertini RJ: T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721, 1990
134. Theocharis S, Sfikakis PP, Lipnick RN, Klipple GL, Steinberg AD, Tsokos GC: Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 74:135-142, 1995
135. Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach J-F: Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 26:472-486, 1996
136. Moens U, Seternes O-M, Hey AW. et al.: In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histories. Proc Natl Acad Sci USA 92:12393-12397, 1995
137. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH: Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 179:1243-1252, 1994
138. Ray SK, Putterman C, Diamond B: Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease. Proc Natl Acad Sci USA 93:2019-2024, 1996
139. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157, 1992
140. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11:729-766, 1993
141. Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolnik AG: Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW)F1 mice. J Exp Med 184:853-861, 1996
142. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371, 1994
143. Sytwu H-K, Liblau RS, McDevitt HO: The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17-30, 1996
144. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233-1237, 1990
145. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994
146. Taylor GA, Carballo E, Lee DM, et al.: A pathogenic role of TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445-454, 1996
147. Wilson AG, Gordon C, Giovine FS, Van de Piutte LB, Emery P, Duff GW: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24:191-195, 1994
148. DeMagistris MT, Alexander J, Coggeshall M, et al.: Antigen analog-Major histocompatibility complexes act as antagonists at the T cell receptor. Cell 68:625-634, 1992
149. Sloan-Lancaster J, Evavold BD, Allen PM: Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 180:1195-1205, 1994
150. Brestcher PA, Cohn M: A theory of self discrimination. Science 169:1042-1049, 1970